As a sequel to the industry-academia idea exchange program that the School of Pharmaceutical Technology has been organising for the past two years, a day long workshop on “GMP NORMS: GLOBAL QUALITY MANAGEMENT IN PHARMACEUTICALS” was held on 18 August 2018. Three eminent speakers from the field of industry, academia and regulatory body spoke on the occasion. Mr. Alok Ghosh, President Global Technical Operations, Lupin Ltd., Mumbai through his lucid presentation gave an account of India’s ascendency as a “Pharmacy of the world” in the pre and post GATT period. While giving an account of how it started its journey, the present status and the future journey that lay before us, he emphasized on innovation for the coming years to improve India’s global presence from five out of ten to a better position. Mr. Ghosh mentioned the Indian advantage in terms of cost, skill and supply chain.
Dr. Tulshi Chakraborty, a former professor of BHU and the Head of Research & Development, Organon India Pvt. Ltd. shared his experience in implementation of GMP and cGMP norms in Indian perspective and touched upon the areas that need to be strengthened and a message that the concept of GMP comes from top.
Dr. Subhash C. Mondal, Chairman Regulatory Affairs Division, spoke on the GMP regulations adopted by India. He urged the audience to look beyond GMP and adopt Quality by design and maintain data integrity to be able to meet the challenges to remain at the top.
The workshop evoked enthusiasm in the industry and institutions around. About 350 participants inclusive of 10 from industries and 50 from other academic institutions took part in the workshop. The workshop ended with a colourful cultural event by the students and faculty members of School of Pharmaceutical Technology.
